Efficacy and tolerance of different types of prophylaxis for prevention of early aspergillosis after heart transplantation

Transplantation Proceedings

Volumn 42, Issue 8, 2010, Pages 3014-3016

  Paniagua Martin, M J ^a   Marzoa Rivas, R ^a   Barge Caballero, E ^a   Grille Cancela, Z ^a   Fernandez, C J ^a   Solla, M ^a   Pedrosa, V ^a   Rodriguez Fernandez, J A ^a   Herrera, J M ^a   Castro Beiras, A ^a   Crespo Leiro, M G ^a  

^a Hospital Universitario A Corua   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; AZATHIOPRINE; BASILIXIMAB; CYCLOSPORIN; ITRACONAZOLE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; STEROID; TACROLIMUS; VORICONAZOLE;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; ARTIFICIAL VENTILATION; ASPERGILLOSIS; ATELECTASIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SUBSTITUTION; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; HEART TRANSPLANTATION; HUMAN; INCIDENCE; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; RESPIRATORY FAILURE; RETROSPECTIVE STUDY; TRACHEA OBSTRUCTION; TRACHEOBRONCHITIS; TREATMENT DURATION;

ADULT; AGED; AMPHOTERICIN B; ANTIFUNGAL AGENTS; ASPERGILLOSIS; FEMALE; HEART TRANSPLANTATION; HUMANS; INCIDENCE; ITRACONAZOLE; MALE; MIDDLE AGED;

EID: 77958609698     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2010.08.013     Document Type: Article

References (10)

1. J.K. Preiksaitis, M. Green, and R.K. Avery Guidelines for prevention and management of infectious complications of solid organ transplantation Am J Transplant 4 supple 10 2004 110
2. O.S. Zmeili, and A.O. Soubani Pulmonary aspergillosis: a clinical update QJM 100 2007 317
3. T.J. Walsh, E.J. Anaissie, and D.W. Denning Treatment of aspergillosis: clinical practice guidelines of Infectious Diseases Society of America Clin Infect Dis 46 2008 327
4. M.J.G.T. Ruping, J.J. Vehreschild, and O.A. Cornely Patients at high risk of invasive fungal infections When and how to treat Drugs 68 2008 1941
5. M. Salavert Prophylaxis, pre-emptive or empirical antifungal therapy: which is best in non-lung transplant recipients Int J Antimicrob Agents 32 supp 2 2008 S149
6. A. Glasmacher, A. Prentice, and M. Gorschluter Itraconazol prevents invasive fungal infections in neutropenic patients treated for hematologic malignancies: evidence from a meta-analysis of 3597 patients J Clin Oncol 21 2003 4615
7. P. Muñoz, C. Rodriguez, and E. Bouza Risk factor of invasive aspergillosis after heart transplantation: protective role of oral itraconazole prophylaxis Am J Transplant 4 2004 636
8. V. Monforte, A. Roma, and J. Gavalda Nebulized amphotericin B prophylaxis for Aspergillus infection in lung transplantation: study of risk factors J Heart Lung Transplant 20 2001 1274
9. V. Monforte, P. Ussetti, and R. López Nebulized liposomal amphotericin B prophylaxis for Aspergillus infection in lung transplantation: pharmacokinetics and safety J Heart Lung Transplant 28 2009 170
10. V. Monforte, P. Ussetti, and J. Gavald Feasibility, tolerability, and outcomes of nebulized liposomal amphotericin B for Aspergillus infection prevention in lung transplantation J Heart Lung Transplant 29 2010 523